🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study, is a Phase I/II clinical trial in three parts: Phase I Dose Esc...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2013-08
Trial ID
NCT01926587
Treatments Being Tested
The goal of this clinical research study is to learn if rigosertib can help...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-08-16
Trial ID
NCT02730884
Treatments Being Tested
This pilot trial studies how rigsertib sodium works in treating patients wi...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2021-08-24
Trial ID
NCT04177498
Treatments Being Tested
This is a phase 1 study in which 2 to 72 patients with advanced cancer will...
Status
Completed
Location
University of Colorado at Denver Health and Sciences
Start Date
2010-07
Trial ID
NCT01168011
Treatments Being Tested
For patients with leukemia who have not responded to or have progressed aft...
Status
Completed
Location
University of Texas M. D. Anderson Cancer Center
Start Date
2010-07
Trial ID
NCT01167166
Treatments Being Tested
This phase II clinical trial tests how well rigosertib plus pembrolizumab w...
Status
Active Not Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-05-09
Trial ID
NCT05764395
Treatments Being Tested
This study will compare the dosing regimen of oral rigosertib, which has be...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2014-05
Trial ID
NCT02075034
Treatments Being Tested
Epidermolysis bullosa (EB) is a heritable skin disease characterized by mar...
Status
Completed
Location
EB House Austria/Dept. of Dermatology University Hospital
Start Date
2021-04-12
Trial ID
NCT03786237
Treatments Being Tested
This is an extension study to investigate long term safety and efficacy of ...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT02002936
Treatments Being Tested
The purpose of this study is to investigate tolerability when SyB C-1101 is...
Status
Completed
Location
Research site
Start Date
2013-03
Trial ID
NCT02014051
Treatments Being Tested